Australia markets closed

T2 Biosystems, Inc. (TTOO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.9900+0.0500 (+1.70%)
At close: 04:00PM EDT
2.9950 +0.00 (+0.17%)
After hours: 06:35PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-64,048
-50,077
-62,003
-49,241
-46,798
Depreciation & amortisation
2,255
859
1,047
2,538
3,156
Stock-based compensation
6,931
4,351
6,493
7,090
3,913
Change in working capital
380
-4,042
-503
-2,171
-6,538
Accounts receivable
2,644
743
2,971
-35
-2,274
Inventory
-840
-744
-949
-1,940
441
Accounts payable
-553
231
-1,566
761
-1,652
Other working capital
-50,644
-48,328
-50,968
-39,334
-44,019
Other non-cash items
2,630
3,002
3,357
3,934
3,310
Net cash provided by operating activities
-50,142
-48,136
-50,629
-38,874
-43,215
Cash flows from investing activities
Investments in property, plant and equipment
-502
-192
-339
-460
-804
Purchases of investments
-
-
-
0
-50,711
Sales/maturities of investments
19,998
0
9,998
25,251
15,250
Net cash used for investing activities
19,496
-192
9,659
24,791
-36,261
Cash flows from financing activities
Debt repayment
-
-
-
-
0
Common stock issued
28,110
52,731
29,162
19,968
85,311
Common stock repurchased
0
0
-330
0
-
Other financing activities
-62
-62
-243
-
-
Net cash used provided by (used for) financing activities
28,545
52,688
29,054
20,535
85,607
Net change in cash
-2,101
4,360
-11,916
6,452
6,131
Cash at beginning of period
23,598
11,880
23,796
17,344
11,213
Cash at end of period
21,497
16,240
11,880
23,796
17,344
Free cash flow
Operating cash flow
-50,142
-48,136
-50,629
-38,874
-43,215
Capital expenditure
-502
-192
-339
-460
-804
Free cash flow
-50,644
-48,328
-50,968
-39,334
-44,019